메뉴 건너뛰기




Volumn 119, Issue 24, 2012, Pages 5678-5687

Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON;

EID: 84862502741     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-09-380519     Document Type: Article
Times cited : (71)

References (49)
  • 1
    • 45149111788 scopus 로고    scopus 로고
    • Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy
    • Peggs KS, Quezada SA, Allison JP. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol Rev. 2008;224:141-165.
    • (2008) Immunol Rev , vol.224 , pp. 141-165
    • Peggs, K.S.1    Quezada, S.A.2    Allison, J.P.3
  • 2
    • 0028791059 scopus 로고
    • Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
    • Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995;270(5238):985- 988.
    • (1995) Science , vol.270 , Issue.5238 , pp. 985-988
    • Waterhouse, P.1    Penninger, J.M.2    Timms, E.3
  • 4
    • 0030586626 scopus 로고    scopus 로고
    • CTLA-4 Blockade Enhances Clinical Disease and Cytokine Production during Experimental Allergic Encephalomyelitis
    • Perrin PJ, Maldonado JH, Davis TA, June CH, Racke MK. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol. 1996;157(4):1333-1336. (Pubitemid 126449068)
    • (1996) Journal of Immunology , vol.157 , Issue.4 , pp. 1333-1336
    • Perrin, P.J.1    Maldonado, J.H.2    Davis, T.A.3    June, C.H.4    Racke, M.K.5
  • 5
    • 2642655282 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
    • Lühder F, Hoglund P, Allison JP, Benoist C, Mathis D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med. 1998;187(3):427-432.
    • (1998) J Exp Med , vol.187 , Issue.3 , pp. 427-432
    • Lühder, F.1    Hoglund, P.2    Allison, J.P.3    Benoist, C.4    Mathis, D.5
  • 6
    • 33947259319 scopus 로고    scopus 로고
    • Immunosuppressive strategies that are mediated by tumor cells
    • DOI 10.1146/annurev.immunol.25.022106.141609
    • Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007;25:267-296. (Pubitemid 46697910)
    • (2007) Annual Review of Immunology , vol.25 , pp. 267-296
    • Rabinovich, G.A.1    Gabrilovich, D.2    Sotomayor, E.M.3
  • 7
    • 0029947568 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by CTLA-4 blockade
    • Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271(5256):1734-1736. (Pubitemid 26102823)
    • (1996) Science , vol.271 , Issue.5256 , pp. 1734-1736
    • Leach, D.R.1    Krummel, M.F.2    Allison, J.P.3
  • 9
    • 0033517152 scopus 로고    scopus 로고
    • Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony- stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation
    • DOI 10.1084/jem.190.3.355
    • van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med. 1999;190(3):355-366. (Pubitemid 29374833)
    • (1999) Journal of Experimental Medicine , vol.190 , Issue.3 , pp. 355-366
    • Van Elsas, A.1    Hurwitz, A.A.2    Allison, J.P.3
  • 10
    • 77954956787 scopus 로고    scopus 로고
    • Current experience with CTLA4-blocking monoclonal antibodies for the treatment of solid tumors
    • Agarwala SS, Ribas A. Current experience with CTLA4-blocking monoclonal antibodies for the treatment of solid tumors. J Immunother. 2010;33(6):557-569.
    • (2010) J Immunother , vol.33 , Issue.6 , pp. 557-569
    • Agarwala, S.S.1    Ribas, A.2
  • 11
    • 79959772576 scopus 로고    scopus 로고
    • Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
    • Robert C, Thomas L, Bondarenko I, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364(26):2517-2526.
    • (2011) N Engl J Med , vol.364 , Issue.26 , pp. 2517-2526
    • Robert, C.1    Thomas, L.2    Bondarenko, I.3
  • 12
    • 24944459890 scopus 로고    scopus 로고
    • Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
    • Attia P, Phan GQ, Maker AV, et al. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol. 2005;23(25):6043-6053.
    • (2005) J Clin Oncol , vol.23 , Issue.25 , pp. 6043-6053
    • Attia, P.1    Phan, G.Q.2    Maker, A.V.3
  • 14
    • 34249868241 scopus 로고    scopus 로고
    • Adoptive T cell therapy for cancer in the clinic
    • DOI 10.1172/JCI32446
    • June CH. Adoptive T cell therapy for cancer in the clinic. J Clin Invest. 2007;117(6):1466-1476. (Pubitemid 46871329)
    • (2007) Journal of Clinical Investigation , vol.117 , Issue.6 , pp. 1466-1476
    • June, C.H.1
  • 15
    • 77649221824 scopus 로고    scopus 로고
    • Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
    • Heslop HE, Slobod KS, Pule MA, et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood. 2010;115(5):925-935.
    • (2010) Blood , vol.115 , Issue.5 , pp. 925-935
    • Heslop, H.E.1    Slobod, K.S.2    Pule, M.A.3
  • 17
    • 55949125601 scopus 로고    scopus 로고
    • Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens
    • Dudley ME, Yang JC, Sherry R, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008;26(32):5233-5239.
    • (2008) J Clin Oncol , vol.26 , Issue.32 , pp. 5233-5239
    • Dudley, M.E.1    Yang, J.C.2    Sherry, R.3
  • 18
    • 24344436369 scopus 로고    scopus 로고
    • Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
    • DOI 10.1038/nature03954, PII N03954
    • Willimsky G, Blankenstein T. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature. 2005;437(7055):141-146. (Pubitemid 41613441)
    • (2005) Nature , vol.437 , Issue.7055 , pp. 141-146
    • Willimsky, G.1    Blankenstein, T.2
  • 19
    • 28544448646 scopus 로고    scopus 로고
    • Supernatural T cells: Genetic modification of T cells for cancer therapy
    • DOI 10.1038/nri1729
    • Kershaw MH, Teng MW, Smyth MJ, Darcy PK. Supernatural T cells: genetic modification of T cells for cancer therapy. Nat Rev Immunol. 2005;5(12):928-940. (Pubitemid 41746762)
    • (2005) Nature Reviews Immunology , vol.5 , Issue.12 , pp. 928-940
    • Kershaw, M.H.1    Teng, M.W.L.2    Smyth, M.J.3    Darcy, P.K.4
  • 21
    • 77956535599 scopus 로고    scopus 로고
    • Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
    • Jena B, Dotti G, Cooper LJ. Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor. Blood. 2010;116(7):1035-1044.
    • (2010) Blood , vol.116 , Issue.7 , pp. 1035-1044
    • Jena, B.1    Dotti, G.2    Cooper, L.J.3
  • 23
    • 67650638846 scopus 로고    scopus 로고
    • T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
    • Di Stasi A, De Angelis B, Rooney CM, et al. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood. 2009;113(25):6392-6402.
    • (2009) Blood , vol.113 , Issue.25 , pp. 6392-6402
    • Di Stasi, A.1    De Angelis, B.2    Rooney, C.M.3
  • 25
    • 0037037582 scopus 로고    scopus 로고
    • Interferon gamma is required for activation-induced death of T lymphocytes
    • Refaeli Y, Van Parijs L, Alexander SI, Abbas AK. Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med. 2002;196(7):999-1005.
    • (2002) J Exp Med , vol.196 , Issue.7 , pp. 999-1005
    • Refaeli, Y.1    Van Parijs, L.2    Alexander, S.I.3    Abbas, A.K.4
  • 26
    • 0025963594 scopus 로고
    • Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation
    • Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med. 1991;173(3):721-730.
    • (1991) J Exp Med , vol.173 , Issue.3 , pp. 721-730
    • Linsley, P.S.1    Brady, W.2    Grosmaire, L.3    Aruffo, A.4    Damle, N.K.5    Ledbetter, J.A.6
  • 27
    • 0028500255 scopus 로고
    • Absence of B7-dependent responses in CD28-deficient mice
    • Green JM, Noel PJ, Sperling AI, et al. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1994;1(6):501-508.
    • (1994) Immunity , vol.1 , Issue.6 , pp. 501-508
    • Green, J.M.1    Noel, P.J.2    Sperling, A.I.3
  • 28
    • 0035221568 scopus 로고    scopus 로고
    • H2 cytokines
    • DOI 10.1038/83144
    • Kane LP, Andres PG, Howland KC, Abbas AK, Weiss A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol. 2001;2(1):37-44. (Pubitemid 33704951)
    • (2001) Nature Immunology , vol.2 , Issue.1 , pp. 37-44
    • Kane, L.P.1    Andres, P.G.2    Howland, K.C.3    Abbas, A.K.4    Weiss, A.5
  • 29
    • 0029120245 scopus 로고
    • CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
    • Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 1995;182(2):459-465.
    • (1995) J Exp Med , vol.182 , Issue.2 , pp. 459-465
    • Krummel, M.F.1    Allison, J.P.2
  • 36
    • 0035576250 scopus 로고    scopus 로고
    • Tumor-specific T cell activation by recombinant immunoreceptors: CD3zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3zeta signaling receptor molecule
    • Hombach A, Wieczarkowiecz A, Marquardt T, et al. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule. J Immunol. 2001;167(11):6123-6131. (Pubitemid 33081538)
    • (2001) Journal of Immunology , vol.167 , Issue.11 , pp. 6123-6131
    • Hombach, A.1    Wieczarkowiecz, A.2    Marquardt, T.3    Heuser, C.4    Usai, L.5    Pohl, C.6    Seliger, B.7    Abken, H.8
  • 37
    • 0037245125 scopus 로고    scopus 로고
    • Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor
    • DOI 10.1189/jlb.0702365
    • Yin L, Schneider H, Rudd CE. Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor. J Leukoc Biol. 2003;73(1):178-182. (Pubitemid 36125689)
    • (2003) Journal of Leukocyte Biology , vol.73 , Issue.1 , pp. 178-182
    • Yin, L.1    Schneider, H.2    Rudd, C.E.3
  • 38
    • 0031405867 scopus 로고    scopus 로고
    • + T cells
    • DOI 10.1016/S1074-7613(00)80406-9
    • Chambers CA, Sullivan TJ, Allison JP. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity. 1997;7(6):885-895. (Pubitemid 28064901)
    • (1997) Immunity , vol.7 , Issue.6 , pp. 885-895
    • Chambers, C.A.1    Sullivan, T.J.2    Allison, J.P.3
  • 40
    • 0031678645 scopus 로고    scopus 로고
    • + T cells
    • DOI 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.0. CO;2-X
    • Chambers CA, Sullivan TJ, Truong T, Allison JP. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur J Immunol. 1998;28(10):3137-3143. (Pubitemid 28470259)
    • (1998) European Journal of Immunology , vol.28 , Issue.10 , pp. 3137-3143
    • Chambers, C.A.1    Sullivan, T.J.2    Truong, T.3    Allison, J.P.4
  • 41
    • 0035869583 scopus 로고    scopus 로고
    • + TCR-transgenic T cells: Lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase
    • Gajewski TF, Fallarino F, Fields PE, Rivas F, Alegre ML. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J Immunol. 2001;166(6):3900-3907. (Pubitemid 32224916)
    • (2001) Journal of Immunology , vol.166 , Issue.6 , pp. 3900-3907
    • Gajewski, T.F.1    Fallarino, F.2    Fields, P.E.3    Rivas, F.4    Alegre, M.-L.5
  • 42
    • 0034131557 scopus 로고    scopus 로고
    • Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
    • Gorelik L, Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 2000;12(2):171-181. (Pubitemid 30398631)
    • (2000) Immunity , vol.12 , Issue.2 , pp. 171-181
    • Gorelik, L.1    Flavell, R.A.2
  • 43
    • 0034770605 scopus 로고    scopus 로고
    • Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells
    • DOI 10.1038/nm1001-1118
    • Gorelik L, Flavell RA. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med. 2001;7(10):1118-1122. (Pubitemid 33010019)
    • (2001) Nature Medicine , vol.7 , Issue.10 , pp. 1118-1122
    • Gorelink, L.1    Flavell, R.A.2
  • 44
    • 55249117972 scopus 로고    scopus 로고
    • Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor
    • Foster AE, Dotti G, Lu A, et al. Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor. J Immunother. 2008;31(5):500-505.
    • (2008) J Immunother , vol.31 , Issue.5 , pp. 500-505
    • Foster, A.E.1    Dotti, G.2    Lu, A.3
  • 45
    • 65249126905 scopus 로고    scopus 로고
    • Adoptive immunotherapy of cancer using CD4(+) T cells
    • Muranski P, Restifo NP. Adoptive immunotherapy of cancer using CD4(+) T cells. Curr Opin Immunol. 2009;21(2):200-208.
    • (2009) Curr Opin Immunol , vol.21 , Issue.2 , pp. 200-208
    • Muranski, P.1    Restifo, N.P.2
  • 47
    • 0037432787 scopus 로고    scopus 로고
    • Requirement for CD4 T cell help in generating functional CD8 T cell memory
    • DOI 10.1126/science.1082305
    • Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300(5617):337-339. (Pubitemid 36433726)
    • (2003) Science , vol.300 , Issue.5617 , pp. 337-339
    • Shedlock, D.J.1    Shen, H.2
  • 49
    • 78449290135 scopus 로고    scopus 로고
    • CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes
    • Bos R, Sherman LA. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. Cancer Res. 2010;70(21):8368-8377.
    • (2010) Cancer Res , vol.70 , Issue.21 , pp. 8368-8377
    • Bos, R.1    Sherman, L.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.